Smart oxygen device may protect tiny lungs in preterm babies

NCT ID NCT06622161

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether an automated oxygen control device (Oxygenie) could keep preterm babies' oxygen levels in a safer range better than manual adjustments by nurses. 26 preterm babies on ventilators were randomly assigned to 12 hours of automated or manual oxygen control, then switched. The main goal was to see how much time their oxygen levels stayed within the target range of 90-94%.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Oxygenie automated oxygen control device

What this could lead to

If it works, this could help preterm babies avoid dangerous oxygen swings, reducing risks of eye and lung problems.

What could go wrong

This is a small, completed crossover study with only 26 babies, so results may not apply to all preterm infants. The device may not work as well in real-world settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRETERM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hyperoxia Hypoxia Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aga Khan University Hospital

    Karachi, Sindh, 74800, Pakistan